Compliance marketplaceHow Cruxi worksFor compliance providersDeal Desk Regulatory Dashboard Free QMSR Scan Consultant Dashboard Provider Dashboard Get Listed – Consultant Get Listed – Provider
Deal Desk

Marketplace & guides

Medical Device Deal Desk Medical Device M&A (Deal Paths) Medical Device Acquisitions Medical Device Acquisitions (Marketplace) Medical Device Company for Sale Distribution Opportunities Medical Device Exit Options Post Buying Interest List an Opportunity Acquisition & Distribution (Long Guide)
510(k) & Regulatory

Regulatory Services

Free 510(k) Device Assessment 510(k) Regulatory Pathway Assessment 510(k) Modification Assessment 510(k) Traditional Submission QMSR / ISO 13485 Readiness Platform Free QMSR Readiness Scan FDA Consultant & Medical Device Consulting 510(k) Cybersecurity Consultants Los Angeles Free 510(k) Checklist Clinical Trial Insurance (UK, EU, US) Clinical Trial Insurance Cost Calculator

510(k) Services

FDA 510k Consultant Classification Predicate Analysis Regulatory Assessment eSTAR Editor Packaging

Electrical Safety

Arc Flash & One-Line Bids As-Built Electrical Drawings Arc Flash Study Quote & Cost 510(k) Electrical Safety & EMC Testing

510(k) Resources

510(k) Demo Project FDA Database for Research Regulatory Analytics eSTAR Guide FDA eSTAR Templates Predicate Analysis Substantial Equivalence Cybersecurity (SAMD) Risk Analysis (ISO 14971) Fees & Timeline Labeling & IFU FDA 510k Consultant vs AI Checklist Guide

510(k) Microservices

Classification Matching Predicate Finding Regulatory Assessment RTA Check

AI Knowledge Base

AI Literature Review Generator Dissertation Literature Review Systematic Review Software Free Citation Generator Universal Toolbar
EU/UK Representatives

Browse Directories

All Provider Directories FDA 510(k) Submission Services marketplace FDA 510(k) Consultant Directory

Platform Directories

EUDAMED M2M Providers eIFU & Implant Card Platforms FDA GUDID Submission Tools

EU/UK Data & Privacy Reps

GDPR Article 27 Representative Do I Need a GDPR Article 27 Representative? GDPR Article 27 Cost Calculator Article 27 Representative Services Article 27 Pricing Comparison GDPR Article 27 Representative List Swiss FADP Representative Do I Need a Swiss FADP Representative? Swiss FADP Representative Cost Calculator Swiss FADP Representative List GPSR Responsible Economic Operator Do I Need a GPSR Responsible Person? GPSR Cost Calculator GPSR FAQs GPSR Marketplace Listing Readiness Calculator GPSR Technical File Readiness Scorecard GPSR Economic Operator Risk Estimator WEEE / EPR Compliance VAT Fiscal Representative DSA Article 13 Legal Representative REACH Only Representative

EU Cosmetics

EU Cosmetics Responsible Person EU/UK Responsible Person (RP/UK RP) CPSR Support PIF Preparation CPNP/SCPN Support Regulatory Consulting + Formula Compliance Testing Coordination & Management Cosmetics RP List Cosmetics Compliance Tools (EU/UK) Cosmetic Launch Diagnostic (60 sec) EU Ingredient Scan EU Claims Risk Scan Amazon Suppression Diagnosis Cosmetic Contract Manufacturing Manufacturing Tools & Guides Manufacturing RFQ Template Generator Private Label Cost Calculator Capability Matcher Wizard
EU Medical & Global Reps

EU/UK Medical Representatives

EU Authorized Representative Do I Need an EU Authorized Representative? EU Authorized Representative Cost Calculator EU Authorized Representative List UK Responsible Person Swiss Authorized Representative Swiss CH-REP Provider Directory Do I Need a CH‑REP? CH‑REP Cost Calculator CH-REP Mandate Scope Gap Calculator CH-REP Transition Timeline Calculator CH-REP Annual Budget Calculator PRRC as a Service Do I Need a PRRC? PRRC Cost Calculator PRRC List

Medical Device Support

EUDAMED Registration Support Importer & Distributor Compliance FDA QMSR Transition & Inspection Readiness eQMS Software Comparison Medical Device Cybersecurity EU AI Act Authorized Representative (GPAI) EU AI Act High-Risk AI Compliance EUDAMED Onboarding & Data Registration

Non-EU Regulatory Reps

FDA U.S. Agent FDA U.S. Agent Cost Calculator U.S. Agent Compliance Checker U.S. Agent Selection Scorecard FDA U.S. Agent List CBAM Verification AU TGA Sponsor Japan MAH / DMAH Brazil ANVISA Local Representative Compare +50 Brazil ANVISA Local Rep Providers ANVISA Local Representative Total Cost Calculator ANVISA Registration Timeline Risk Estimator ANVISA Documentation Readiness Scorecard ANVISA Portuguese Labeling Readiness Calculator ANVISA Change Impact Calculator ANVISA Post-Market Workload Calculator
Testing & Enforcement

Testing Services

Electrical Safety + EMC Testing (IEC 60601) Wireless / RF Testing (FCC / RED / ISED) Biocompatibility Testing (ISO 10993 Program) Sterilization + Microbiology Validation Packaging + Shelf-life + Distribution Testing Usability / Human Factors Testing

FDA Enforcement & Recall

FDA Import Alert & Detention Assistance Form 483 Response Team Form FDA 483 Response Provider Directory Form FDA 483 Readiness Calculator Form FDA 483 CAPA Timeline Calculator Form FDA 483 Remediation Cost Calculator Recall & 21 CFR 806 Support Recall & 21 CFR 806 Provider Directory 21 CFR 806 Reportability Decision Calculator Recall Action Timeline Calculator Recall & 806 Remediation Cost Calculator

FDA U.S. Agent Information

Medical Device Establishment Registration 21 CFR 807.40 Requirements U.S. Agent vs Official Correspondent Change U.S. Agent in FURLS U.S. Agent Address Requirements Confirm Notification Receipt Code U.S. Agent Role for Inspections U.S. Agent for IVD Manufacturer U.S. Agent for Contract Manufacturer U.S. Agent Cost Per Year Affordable U.S. Agent Service U.S. Agent for Foreign Drug Establishment 21 CFR 207.69 U.S. Agent Food Facility Registration U.S. Agent Food Facility Renewal Confirmation

Cost Calculators

Biocompatibility Testing Cost Calculator Biocompatibility Testing Labs in India EU/UK Cosmetics RP Cost Calculator
Company & Legal
About Cruxi Contact Pricing & Credits Editorial Posting & Sponsorships Blog Careers

Use Cases

Medical Device 510(k) Submission QMSR / ISO 13485 Readiness Free QMSR Readiness Scan PhD & Masters Students Medical Research Academic Writing Legal Teams

Consulting & Resources

FDA 510k Consultant Network FDA Consultant Near Me & Medical Device Consulting 510(k) Cybersecurity Consultants Los Angeles Find 510k Consultants by Specialty FDA Mock Audit Consultants ISO 13485 Consultants ISO 14971 Consultants 510k Consultant Pricing Models 7 Red Flags When Hiring a 510k Consultant Combine 510k Consultants with AI Tools How to Scope a 510k Consultant Project

General Resources

Traditional vs AI Methods Features FAQ 510k Consultant Engagement Guide (PDF)

Legal & Policies

How Cruxi Protects Your Data Security GDPR Compliance Privacy Policy Compliance & Contacts Trust & Listings Cookie Policy Subprocessors EU/UK Article 27 Representative Data Subject Request Data Processing Agreement Terms of Service Consultant Terms Provider Terms Book Now T&C (Clients) Book Now T&C (Providers) Refund Policy Payment Terms Credit Usage Policy Cancellation Policy Support Policy

For Consultants

Apply to Consultant Network

For Service Providers

Join Provider Network Apply Now

Account

Provider Dashboard Consultant Dashboard
About Contact Pricing Blog All Directories Privacy Terms

Reported risk evidence comparison

Cosmetics: plasticizers — reported risk evidence

The acquired cohort contains 65 official alert references published from 2006-04-14 to 2026-05-01. This page compares 8 selected, distinct product descriptions, including bath bomb set, false nails set, hair wax. The other 57 records still contribute to the cohort counts but are not displayed: descriptions may repeat, lack the display inputs, or fall outside the eight-description display limit. The recorded risks raise separate evidence questions about plasticizers. Compare the product features and dated findings below before scoping an investigation. These historical observations do not determine your product’s compliance or a market failure rate.

Evidence retrieved 2026-10-07. Source versions and topic-specific limits are listed below.

Dated official observations

Compare the product features and reported failure mechanism

The source wording below describes the reported case at that time. Read each complete report before using it in an investigation.

Bath bomb set · SR/01316/26

Report published 2026-05-01 · notifying country United Kingdom in respect of Northern Ireland · reported origin France

Reported product description
Bath bomb set All batch numbers are affected. [1]
Reported risk explanation
The label on the Elsa shower puff included in the set has an excessive concentration of phthalates. Phthalates may harm the health of children, possibly causing damage to the reproductive system. The product does not comply with the REACH Regulation. [1]
Reported measures, verbatim
Type of economic operator taking notified measure(s): ImporterCategory of measure(s): Recall of the product from end usersDate of entry into force: 26/03/2026 [1]

Read the official alert ↗

False nails set · SR/03820/25

Report published 2025-10-31 · notifying country Czechia · reported origin People's Republic of China

Reported product description
Set of plastic nails painted in different colours (12 pieces), supplied with glue in a red tube with a white plastic cap [2]
Reported risk explanation
According to the list of ingredients, the glue contains dibutyl phthalate (DBP), which use is forbidden in cosmetic products.This phthalate may harm the health of person, causing possible damage to their reproductive system or the unborn child. The product does not comply with the Cosmetic Products Regulation. [2]
Reported measures, verbatim
Type of economic operator to whom the measure(s) were ordered: RetailerCategory of measure(s): Destruction of the productDate of entry into force: 14/10/2025 [2]

Read the official alert ↗

Hair wax · SR/03403/25

Report published 2025-10-03 · notifying country Germany · reported origin Türkiye

Reported product description
Clear blue scented hair wax paste, 100 ml. Product sold online, in particular via www.laynel.de. [3]
Reported risk explanation
The product contains dibutyl phthalate (DBP) (measured value up to 0.00083 % by weight). This phthalate may harm the health, causing possible damage to the reproductive system or the unborn child. The product does not comply with the Cosmetic Products Regulation. [3]
Reported measures, verbatim
Type of economic operator taking notified measure(s): DistributorCategory of measure(s): Withdrawal of the product from the marketDate of entry into force: 28/08/2025Type of economic operator taking notified measure(s): DistributorCategory of measure(s): Stop of salesDate of entry into force: 28/08/2025Type of economic operator taking notified measure(s): DistributorCategory of measure(s): Recall of the product from end usersDate of entry into force: 28/08/2025 [3]

Read the official alert ↗

False nails with glue · SR/03035/25

Report published 2025-08-22 · notifying country Czechia · reported origin People's Republic of China

Reported product description
Set of plastic nails painted in different colours (12 or 24 pieces), supplied with glue in an orange tube. [4]
Reported risk explanation
According to the list of ingredients, the glue contains dibutyl phthalate (DBP), which is forbidden in cosmetic products. This phthalate may harm the health, possibly causing damage to the reproductive system or the unborn child. The product does not comply with the Cosmetic Products Regulation. [4]
Reported measures, verbatim
Type of economic operator to whom the measure(s) were ordered: RetailerCategory of measure(s): Destruction of the productDate of entry into force: 06/08/2025 [4]

Read the official alert ↗

Nail polish · A12/0290/18

Report published 2018-03-02 · notifying country Romania · reported origin Unknown

Reported product description
Nail polish, available in different colours. [5]
Reported risk explanation
The product contains dibutyl phthalate which is toxic to reproduction. The product does not comply with the Cosmetic Products Regulation. [5]
Reported measures, verbatim
Type of economic operator to whom the measure(s) were ordered: OtherCategory of measure(s): Withdrawal of the product from the marketDate of entry into force: 21/06/2017 [5]

Read the official alert ↗

Nail polish remover · A12/0755/16

Report published 2016-06-24 · notifying country Romania · reported origin United States

Reported product description
Bottle (60ml) containing nail polish remover. [6]
Reported risk explanation
null The label of the nail polish remover indicates the presence of dibutyl phtalate (DBP) which is toxic to reproduction.The product does not comply with the Cosmetic Products Regulation. [6]
Reported measures, verbatim
Type of economic operator to whom the measure(s) were ordered: OtherCategory of measure(s): Withdrawal of the product from the marketDate of entry into force: 16/05/2016 [6]

Read the official alert ↗

Nail polish · A12/0596/14

Report published 2014-04-25 · notifying country Czechia · reported origin Czechia

Reported product description
Nail polish in glass bottle with blue lacquer and black plastic cap. Volume 11 ml. [7]
Reported risk explanation
null This product poses chemical risk because it contains dibutyl phthalate (measured value: 4.7%).The product does not comply with the Cosmetic Products Regulation. [7]
Reported measures, verbatim
Type of economic operator to whom the measure(s) were ordered: OtherCategory of measure(s): Withdrawal of the product from the marketDate of entry into force: 26/03/2014 [7]

Read the official alert ↗

Nail polish · A12/0305/14

Report published 2014-02-28 · notifying country Finland · reported origin People's Republic of China

Reported product description
An assortment of nail polishes in different colours. Each colour is packed in a flower shaped glass bottle with golden cap. The assortment is packed in a cardboard package, which contains the list of ingredients. [8]
Reported risk explanation
null The product poses a chemical risk because it contains dibutyl phthalate (DBP).The product does not comply with the Cosmetic Products Regulation. [8]
Reported measures, verbatim
Type of economic operator to whom the measure(s) were ordered: OtherCategory of measure(s): Import rejected at borderDate of entry into force: 30/01/2014 [8]

Read the official alert ↗

What this acquired cohort contains

65 distinct official alert references, published between 2006-04-14 and 2026-05-01. Counts describe the acquired reports, with no market denominator.

Report yearRecorded alerts
200613
200719
20084
20095
20105
20115
20125
20142
20161
20181
20221
20253
20261

Recorded risk labels within this evidence task

Label combinations are source facts within one comparison; they do not create separate guides with identical preparation tasks.

Source selection, exclusions and calculation method

Filter the acquired, completely parsed English weekly XML releases. Deduplicate official alert references. Group by product category and the complete set of conditional evidence-question topics supported by actual risk text. Risk-label combinations remain recorded cohort facets and do not create buyer intents. Brand, product name, model, origin, notifying country, measurement-only changes and different wording of the same questions do not create intents. Unrecognized mechanisms stay internal for enrichment. Count report years and notifying countries deterministically. Display at most eight newest descriptions with at least 40 characters after whitespace normalization, nonempty reported measures and distinct casefolded descriptions; break date ties by official identifier. All cohort records count even if their description is shorter or not displayed. This is not a representative sample. Counts concern this acquired corpus only.

One acquired version per official public alert reference. Display at most eight newest distinct product descriptions whose normalized whitespace-collapsed text contains at least 40 characters and has nonempty reported measures; ties sort by official identifier. The complete cohort includes shorter descriptions. This is an explicit display selection, not a representative sample.

8 distinct descriptions displayed; 57 cohort records not displayed. Missing fields: {'measures': 10, 'description': 3}.

These are selected, dated enforcement observations in the acquired weekly reports, not a random market sample, market-wide failure rate, proof of current product status, or a determination about your product. Notification country is not a complete sales-market or jurisdiction-coverage field. A quoted legal/standard reference is the report’s statement, not independently verified current law or a mandatory test panel.

Calculation safety-gate-evidence-comparison-10; units recorded alerts; no incidence denominator.

Turn the reported failure mechanism into a scoped investigation

Use this checklist to gather your business or product details before speaking with a specialist. The items below explain what to record and suggest useful supporting documents. You can add your own answers in the editable project brief.

  1. Plasticizer identity, material and use — what evidence do we have?

    Identify the actual plasticizer/substance and polymer/component, with composition and use/exposure facts. Similar abbreviations or a general “phthalates” label do not resolve exact identity or applicable conditions. Keep concentrations and legal scope questions separate.

    Useful evidence: Supplier substance/CAS/EC identities, composition and material records, sampled-component results and exact use/actor context.

    Reported context: [1], [2], [3], [4], [5], [6], [7], [8]

  2. Can we trace the affected component, formula or design revision across our supplied products?

    Compare the reported descriptions with your own identifiers and change records. Treat missing or “Unknown” source fields as unresolved; they do not establish that no action was needed.

    Useful evidence: Product identifiers, revision history, supplier/batch traceability and market/operator records.

  3. Who would own an evidence review and any resulting corrective-action decision?

    Read the reported measures as historical observations. Establish your own operator roles, sector-specific rules, decision owner and communication responsibilities before adopting another case’s response.

    Useful evidence: Supply-chain responsibility map, applicable-law review, investigation scope and documented decision/communication workflow.

Work packages and dependencies

Questions for providers

Sources and data dates

Read the official document in context. The audit details identify the precise locators and preserved versions used for this page.

Prepare an editable project brief

Confirm the facts, scope and contact preference before sharing your project. Preparing this page sends no provider outreach.

Choose work packages to discuss

Compare EU+UK Cosmetics Compliance